Renishaw Announces Milestone in Parkinson’s Study Using 3D Printed Apparatus
UK-based engineering technologies company, Renishaw, has announced a milestone in a medical study seeking to help sufferers with progressive nervous system disorder Parkinson disease. The study looks at a patented intraparenchymal drug delivery device and is the completion of a joint Phase 1-2 clinical study with pharmaceuticals expert Herantis Pharma.
